About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
503
By Phase
PHASE2: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
Today
Hover over trial bars to see details
Recent Trials
NCT02103959Lead Sponsor
Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
PHASE2Completed
361 participants
Started: Jun 30, 2014 · Completed: Dec 31, 2015
NCT00984802Lead Sponsor
Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy
PHASE2Completed
142 participants
Started: Feb 28, 2010 · Completed: Apr 30, 2011
Funding History (1)
D
Jun 5, 2014
Locations (1)
Headquarters
Grafton, MA, United States
Map
Loading map...